NCT03525639View on ClinicalTrials.gov

CMR Evaluation of Myocardial Inflammation Persistence After Acute Myocarditis: Prognostic Relevance

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 6, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

February 20, 2021

Conditions
Myocarditis AcuteMyocardial Inflammation
Interventions
DIAGNOSTIC_TEST

Cardiac Magnetic Resonance

Additional CMR study 2 month after the initial diagnosis of acute myocarditis to assess myocardial inflammation persistence (2-month-CMR).

Trial Locations (3)

20132

IRCCS San Raffaele, Milan

Unknown

Policlinico Umberto I, Roma

AOU Città della Salute e della Scienza, Torino

All Listed Sponsors
collaborator

Ministry of Health, Italy

OTHER_GOV

lead

Antonio Esposito

OTHER

NCT03525639 - CMR Evaluation of Myocardial Inflammation Persistence After Acute Myocarditis: Prognostic Relevance | Biotech Hunter | Biotech Hunter